The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has published a new report entitled “Multiple Criteria Decision Analysis for Health Care Decision Making – An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force, ” in its January/February 2016 issue of Value in Health (Volume 19, Issue 1).

MCDA is increasingly used to support healthcare decision making, including molecule investment decisions, patient-centered benefit risk assessment, health technology assessment, and prescription decisions. The diversity of MCDA methods, however, can be an obstacle to researchers. The Task Force was established to help define MCDA and provide good practice recommendations for its use in healthcare. The Task Force outputs will help advance the use of MCDA in healthcare by providing a sound basis for researchers and policy makers to determine which MCDA approach is appropriate for their needs, and then support them to implement the chosen approach.

More information on the ISPOR Task Force, including its first report, can be found on its website. A second report on recommendations on Emerging Good Practices is currently in development and is anticipated to be published in the March/April 2016 issue of Value in Health.

For more information on MCDA go to